Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 15/20 | 0.51 |
| ▸ | KDM6B | O15054 | 7/20 | 0.51 |
| ▸ | KDM4D | Q6B0I6 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | KDM4A | O75164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | GABRP | O00591 | 2/20 | 0.49 |
| ▸ | GABRD | O14764 | 2/20 | 0.49 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.49 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.49 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.49 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.49 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.49 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30465694 | 1.00 | KDM4C (0.51) | KDM4CKDM6BKDM4DTDP1KDM4E | |
| Acetic Acid SCHEMBL16666943 | 0.96 | KDM4C (0.49) | KDM4CKDM6BKDM4DTDP1KDM4E | |
| SCHEMBL258369 | 0.87 | KDM4C (0.51) | KDM4CKDM6BKDM4DTDP1KDM4E | |
| Hydrochloric Acid SCHEMBL5739434 | 0.85 | KDM4C (0.50) | KDM4CKDM6BKDM4DTDP1KDM4E | |
| SCHEMBL115648 | 0.84 | KDM4C (0.56) | KDM4CKDM6BKDM4DTDP1KDM4E | |
| SCHEMBL3880004 | 0.84 | KDM4C (0.50) | KDM4CKDM6BKDM4DTDP1KDM4E | |
| SCHEMBL30100781 | 0.84 | KDM4C (0.56) | KDM4CKDM6BKDM4DTDP1KDM4E | |
| SCHEMBL3818724 | 0.84 | TDP1 (0.44) | KDM4CKDM6BKDM4DTDP1KDM4E | |
| SCHEMBL4005290 | 0.84 | GABRP (0.55) | KDM4CKDM6BKDM4DTDP1KDM4E | |
| SCHEMBL2370442 | 0.83 | KDM4C (0.46) | KDM4CKDM6BKDM4DTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118525087-A | Lipase formulations and methods thereof | 第一浪潮生物制药有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-116437947-A | Non-pig formulations and methods thereof | 第一浪潮生物制药有限公司 | 2023-07-14 | — | — | CN | claimed |
| EP-2788323-B1 | NEW PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF VILDAGLIPTIN | CHEMELECTIVA SRL (IT) | 2017-01-11 | — | — | EP | claimed |
| EP-2788323-A1 | NEW PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF VILDAGLIPTIN | Chemelectiva Srl. (IT) | 2014-10-15 | — | — | EP | claimed |
| WO-2013083326-A1 | NEW PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF VILDAGLIPTIN | CHEMELECTIVA S.R.L. (IT) | 2013-06-13 | — | — | WO | claimed |
| US-7887840-B2 | Bioavailability of low- solubility drugs | BEND RESEARCH, INC. (US) | 2011-02-15 | — | — | US | claimed |
| EP-2275091-A1 | Pharmaceutical compositions comprising adsorbates of an amorphous drug | Pfizer Products Inc. (US) | 2011-01-19 | — | — | EP | claimed |
| US-20040147491-A1 | Prevent, maintenance of Dna damage; administering compound which forms nicotinamide-adenine dinucleotide | NIADYNE, INC. | 2004-07-29 | — | — | US | claimed |
| US-20010033848-A1 | Adjustment of cellular nicotinamide-adenine dinucleotide | NIADYNE, INC. | 2001-10-25 | — | — | US | claimed |
| EP-1143954-A2 | USE OF NICOTONIC ACID DERIVATIVES FOR THE TREATMENT OF DNA DAMAGE IN SKIN CELLS | University of Kentucky Research Foundation (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000032179-A2 | USE OF NICOTONIC ACID DERIVATIVES FOR THE TREATMENT OF DNA DAMAGE IN SKIN CELLS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2000-06-08 | — | — | WO | claimed |
| US-5259992-A | Cuprous iodide-pyridine derivative complex | REXHAM GRAPHICS INC. (US) | 1993-11-09 | — | — | US | claimed |
| EP-0117080-B1 | SKIN TREATMENT COMPOSITION | UNILEVER PLC (GB) | 1992-04-08 | — | — | EP | claimed |
| US-12595245-B2 | Inhibitors of MET kinase | CELYN THERAPEUTICS, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| CN-121779373-A | Synthesis method of imazethapyr | 辽宁优创植物保护有限公司 | 2026-04-03 | — | — | CN | disclosed |
| EP-4192833-B1 | PHARMACOLOGICALLY ACTIVE HETEROCYCLIC-SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES | RICHTER GEDEON NYRT (HU) | 2026-01-21 | — | — | EP | disclosed |
| US-4576755-A | Water-soluble fibre-reactive phthalocyanine compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-03-18 | — | — | US | disclosed |
| EP-0075905-B1 | WATER-SOLUBLE REACTIVE PHTHALOCYANINE COMPOUNDS; PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-01-15 | — | — | EP | disclosed |
| EP-0075905-A2 | Water-soluble reactive phthalocyanine compounds; process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-04-06 | — | — | EP | disclosed |
| US-4237050-A | Process for the preparation of water-soluble phthalocyanine dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595245-B2 | Inhibitors of MET kinase | MET, ABL1, ERBB2 | KDM4C 721/4885KDM6B 518/4885KDM4D 608/4885 |
| US-20040147491-A1 | Prevent, maintenance of Dna damage; administering compound which forms nicotinamide-adenine dinucleotide | NQO1, NNT, NAMPT | KDM4C 3353/4885KDM6B 3566/4885KDM4D 2995/4885 |
| US-20010033848-A1 | Adjustment of cellular nicotinamide-adenine dinucleotide | NQO1, NNT, NAMPT | KDM4C 3290/4885KDM6B 3163/4885KDM4D 3036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.